Gen Xers are getting more joint replacements
Many patients in their 50s simply want to end chronic joint pain from arthritis, injuries and years of wear and tear to get back to hiking or to take up pickleball.
Health Care & Life Sciences
Articles
Elanco CEO says new products helping to turn the corner on growth
Elanco Animal Health last week released what CEO Jeff Simmons called its best quarterly earnings since its 2018 spinoff from Eli Lilly and Co.
Lilly hikes obesity shot price in UK as Trump pressures drugmakers
Trump sent letters to 17 of the world’s largest drugmakers earlier this month, including Lilly and Novo Nordisk A/S, insisting they lower what they charge Medicaid in the U.S. for existing drugs.
Texas AG: Eli Lilly and Co. offered kickbacks to providers to prescribe blockbuster drugs
The complaint alleges the Indianapolis-based drugmaker offered illegal incentives to influence Texas providers to prescribe Lilly medications including Zepbound and Mounjaro.
Firm tied to Trump Jr. debuts direct sales product for pharma companies
Eli Lilly and Co. has already launched LillyDirect service, which CEO David Ricks says jibes with the administration’s demand for direct sales. Lilly is working with Truepill and Amazon.com Inc.’s pharmacy unit on its platform.
UPDATE: Elanco shares jump 16% as company raises full-year guidance
The company, which makes vaccines, antibiotics and other animal-health products, said it now expects full-year revenue of between $4.57 billion and $4.62 billion.
IU lands $16.5M grant to advance Alzheimer’s research using 3D brain modeling
The grant will fund a new center at the medical school which will be one of only two in the U.S. dedicated to developing stem-cell-based models of the brain to better understand Alzheimer’s disease.
UIndy embraces growing role for nurse practitioners in hospitals
The University of Indianapolis is launching a program this month to prepare nurse practitioners, long a fixture in primary care exam rooms, to care for complex and critically ill patients in hospitals.
Roche to test whether new drug can prevent Alzheimer’s
The new late-stage study will focus on people who are at risk of cognitive decline.
Drug manufacturing facility offers new hope in cancer fight
New Jersey-based drugmaker Bristol Myers Squibb this month dedicated its first production facility in Indiana, a former north-side warehouse transformed with $160 million into a clean-room manufacturing site for radiopharmaceutical cancer therapies.
Lilly gets limited European backing for Alzheimer’s drug
Lilly previously secured approval for Kisunla in the U.S., Japan and the U.K.
IU Health rethinks design of patient rooms
The health care system is making big changes, down to the smallest details, for the 864 patient rooms in the academic hospital system’s massive new downtown hospital.
Animal-health startup BiomEdit advances poultry antibody, lands $20M in funding, grants
BiomEdit said the disease it’s targeting, avian necrotic enteritis, causes an estimated $6 billion in annual losses worldwide.
Longtime Community Health CEO Bryan Mills to retire
Mills joined Community in 1985 when it was a single hospital. Today, it operates five acute-care hospitals (with a sixth in the works), a cardiovascular hospital, a recovery center, three rehabilitation hospitals and a freestanding behavioral health hospital.
‘Narrow’ health plans gain wider acceptance
Direct-to-employer health insurance plans, in which an employer contracts directly with a health care network for coverage, restrict provider choice but are generally less expensive for employers and employees.
IU School of Medicine opens new $230M education and research building
The school’s primary classroom and education facility is being moved from its longtime home on the Indianapolis campus to be closer to the new IU Health teaching hospital, set to open in 2027.
IU professor’s work leads to Alzheimer’s blood test
Indiana University School of Medicine researcher Jeff Dage’s years of research into biomarkers helped lead to a first-of-its-kind blood test to diagnose Alzheimer’s disease.
Lilly hosts Reddit ‘Ask Me Anything’ Q&A on blockbuster weight-loss drug Zepbound
Questions included whether the Indianapolis-based drugmaker is working to improve insurance coverage for the drug and highlighted users’ concerns about comparisons with Novo Nordisk’s Wegovy.
FDA to offer faster drug reviews to companies promoting ‘national priorities’
Food and Drug Administration Commissioner Marty Makary said the agency will aim to review select drugs in one to two months.
Lilly acquires cardiovascular genetic medicine company for up to $1.3B
Boston-based Verve Therapeutics is a Nasdaq-traded company focused on genetic medicines for cardiovascular disease.